VEGFA and ovarian carcinoma: Immunohistochemical analysis of expression of VEGFA, VEGFC and VEGFD in ovarian carcinoma patients, most of which (92/100) were diagnosed with FIGO Stage III disease with retroperitoneal metastases or those with predominantly intraperitoneal metastasis, demonstrated that high expression of VEGFC corresponded to the presence of the retroperitoneal metastasis, while low VEGFC correlated with mostly intraperitoneal metastatic spread, supporting the role of VEGFC–VEGFR3 interaction in EOC cell tropism to the lymph node.